Pentadecapeptide Bpc 157 Human Growth Hormone Supplements Peptide Peptide Drum CAS 137525-51-0

Product

Pentadecapeptide Bpc 157 Human Growth Hormone Supplements Peptide Pept...

Posting date : Mar 25, 2017

Click enlarge Image

Membership

Free Member Scince Mar 24, 2017

FOB Price

Min. Order Quantity

2mg

Supply Abillity

2000kg/week

Port

Guangzhou

Payment Terms

T/T, Bank Transfer, Western Union, Paypal

Package

According to your requirements

Keyword :

Peptide

Category

Contact

Tont

0 likes

Product Detail

Company Info

Quick Detail

Place of Origin

China [CN]

Brand Name

Kafen

Model Number

137525-51-0

HS-CODE

Package & Delivery Lead Time

Package

According to your requirements

Delivery Lead Time

Within 12 hours after receiving your payment

Detailed Description

Pentadecapeptide Bpc 157 Human Growth Hormone Supplements Peptide Peptide Drum CAS 137525-51-0

Basic Info.

Alias : Booly Protection Compound 15, Pentadecapeptide, BPC 157 CAS : 137525-51-0 Sequence : Gly-Glu-Pro-Pro-Pro-Gly- Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val MF : C62H98N16O22 MW : 1419.53552 Purity : 99% Specification : 2mg/vial Appearance : White Lyophilized Powder Standard : USP Certification : SGS Method of Analysis : HPLC Storage : Lyophilized peptides although stable at room temperature for 3 months, should be stored desiccated below -18° C. Upon reconstitution of the peptide it should be stored at 4° C between 2-21 days and for future use below -18°C.

Description:

Pentadecapeptide BPC 157, composed of 15 amino acids, is a partial sequence of body protectioncompound (BPC) Pentadecapeptide BPC 157, composed of 15 amino acids, is a partial sequence of body protection compound (BPC) that is discovered in and isolated from human gastric juice.The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration Stable gastric pentadecapeptide BPC 157 (GEPPPGKPADDAGLV, M.W. 1419) may be the new drug stable in human gastric juice, effective both in the upper and lower GI tract, and free of side effects.

BPC 157, in addition to an antiulcer effect efficient in therapy of inflammatory bowel disease (IBD)(PL 14736) so far only tested in clinical phase II, has a very safe profile, and exhibited a particular wound healing effect. It also has shown to interact with the NO-saystem, providing endothelium protection and angiogenic effect, even in severely impaired conditions (i.e., it stimulated expression of early growth response 1 gene responsible for cytokine and factor generation and early extracellular matrix (collagen) formation (but also its repressor nerve factor 1- A binding protein-2)), important to counteract severe complications of advanced and poorly controlled IBD. Hopefully, the lessons from animal studies, particularly advanced intestinal anastomosis healing, reversed short bowel syndrome and fistula healing indicate BPC 157s high significance in further IBD therapy. Also, this supportive evidence (i.e., no toxic effect, limit test negative, LD1 not achieved, no side effect in trials) may counteract the problems commonly exercised in the use of peptidergic agents, particularly those used on a long-term basis

Application: 1. BPC 157 has a strong anti-inflammatory activity in both acute and chronic inflammation models. In fact, preliminary results in clinical trials suggest that BPC 157 may become an important therapeutic tool for the treatment of inflammatory bowel disease. 2. BPC 157 was shown to accelerate wound healing and to have a marked angiogenic effect. In addition, it significantly facilitates the healing of bone fracture in rats. This peptide also exhibits an osteogenic effect significantly improving the healing of segmental bone defect. BPC 157 accelerates the healing of transected rat Achilles tendon and transected rat quadriceps muscle. 3. FITC-phalloidin staining was able to demonstrate that BPC 157 induces F-actin formation in fibroblasts. Likewise, Western blot analysis was able to detect the production and activation of paxillin and FAK proteins. The western blot analysis also showed that BPC 157 increases the extent of phosphorylation of paxillin and FAK proteins without affecting the amounts produced.